Themis Medicare Limited has announced the opening of a special window for shareholders to address pending share transfer requests and facilitate dematerialization of physical securities. This initiative follows regulatory guidelines established by the Securities and Exchange Board of India (SEBI) and aims to help investors regularize their shareholding status.

Special Window Details

The company has opened a one-year special window from February 05, 2026 to February 04, 2027, pursuant to SEBI Circular No. HD/38/13/11(2)2026-MIRSDPOD/1/3750/2026 dated January 30, 2026. This facility specifically targets shareholders who had transactions prior to April 01, 2019 but faced challenges in completing the transfer process.

Eligibility Criteria

The special window is available to shareholders of Themis Medicare Limited who meet specific conditions. The company has provided a detailed eligibility matrix to clarify qualification requirements:

Process Requirements and Restrictions

Shareholders seeking to utilize this special window must submit original share certificates along with transfer deeds and supporting documents. The company emphasizes that only requests accompanied by complete documentation will be considered under this facility.

Shares successfully transferred through this window will be mandatorily credited to the transferee in dematerialized (Demat) mode only. Additionally, these shares will be subject to a lock-in period of one year from the date of registration of transfer, during which they cannot be transferred, lien marked, or pledged.

Contact Information and Resources

Shareholders interested in availing this special window facility can contact the company's Registrar & Transfer Agent, MUFG Intime India Private Limited (formerly known as Link Intime India Private Limited). The RTA is located at C-101, Embassy 247, L.B.S. Marg, Vikhroli (West), Mumbai-400083.

The complete SEBI Circular is available on the company's website at https://www.themismedicare.com/investor-relations/investornews for detailed reference. The company encourages all eligible investors to initiate necessary actions without delay to regularize their pending transfer cases during this special window period.

Themis Medicare Limited has successfully concluded its postal ballot process, with shareholders approving all four proposed resolutions through remote e-voting. The company announced the results on 28th March, 2026, following the completion of the voting period on 27th March, 2026.

Postal Ballot Overview

The postal ballot was conducted in accordance with the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The voting process was overseen by Mr. Abhishek Wagh, Company Secretary (ACS 65319) of M/s. Abhishek Wagh & Associates, who was appointed as scrutinizer through a board resolution dated 13th February, 2026.

Resolution-wise Voting Results

All four resolutions received overwhelming shareholder support, with approval rates exceeding 99% for each proposal.

Resolution 1: Material Related Party Transactions

The first ordinary resolution approved material related party transactions with Themis Distributors Private Limited or Vividhmargi Investments Private Limited post-merger.

Resolution 2: Gujarat Themis Biosyn Limited Transactions

The second ordinary resolution approved material related party transactions with Gujarat Themis Biosyn Limited (GTBL).

Resolution 3: Dr. Sachin D. Patel Transaction

The third ordinary resolution approved material related party transactions with Dr. Sachin D. Patel up to Rs. 130 crores for promoters' inter-se transfer of equity shares of Gujarat Themis Biosyn Limited.

Resolution 4: Convertible Warrants Issuance

The special resolution approved the issuance of convertible warrants to Vividhmargi Investments Private Limited on a preferential basis.

Scrutinizer's Observations

The scrutinizer's report highlighted that promoter group votes were considered invalid for the first three resolutions as per Regulation 23 of SEBI (LODR) Regulations, 2015, since these involved related party transactions. A total of 2355780 promoter group votes were classified as invalid for resolutions 1-3, while no invalid votes were recorded for resolution 4.

The company confirmed that shareholders were provided an opportunity to comment on a corrigendum issued on 11th March, 2026, concerning modifications to Resolution 4, but no comments were received within the prescribed 48-hour period.

Compliance and Documentation

The postal ballot process was conducted entirely through electronic voting, with no physical ballot forms dispatched to shareholders. The company published advertisements in 'Indian Express' (English) and 'Financial Express' (Gujarati) newspapers on 26th February, 2026, informing shareholders about the completion of notice dispatch and e-voting procedures.

The voting results and scrutinizer's report have been made available on the company's website at www.themismedicare.com , ensuring transparency and regulatory compliance.